Back to Journals » Clinical Ophthalmology » Volume 15

“Anterior Chamber Depth After Phacovitrectomy” – Response to Letter to the Editor [Response to Letter]

Authors Katz G , el Zhalka F, Veksler R, Ayalon A, Moisseiev E

Received 14 June 2021

Accepted for publication 14 June 2021

Published 28 June 2021 Volume 2021:15 Pages 2813—2814


Gabriel Katz,1,2 Fidaa el Zhalka,3 Ronel Veksler,1 Anfisa Ayalon,3 Elad Moisseiev2,3

1Department of Ophthalmology, Sheba Medical Center, Ramat Gan, Israel; 2Sackler School of Medicine, TelAviv University, TelAviv, Israel; 3Department of Ophthalmology, Meir Medical Center, Kfar Saba, Israel

Correspondence: Elad Moisseiev
Department of Ophthalmology, Meir Medical Center, 59 Tshernichovsky St, Kfar Saba 4428164, Israel
Email [email protected]

View the original paper by Dr Katz and colleagues

This is in response to the Letter to the Editor

Dear Editor

We appreciate the interest of De Bernardo et al in our study. Some of the remarks made are interesting but most of them relate to simple limitations of the study. Here is our response to the issues that were presented by the authors:

  1. The anterior chamber depth (ACD) increase is a well-known fact after cataract surgery. It was also shown that the ACD is slightly larger in vitrectomized eyes vs non-vitrectomized eyes.1 The slightly lower accuracy of the predicted refraction after combined phaco-vitrectomy with a small myopic shift was also shown in previous studies.2,3
  2. The scope of this study was to look at the ACD after surgery as a post-surgery measurement of the effective lens position (ELP). We wanted to find whether it correlates with the post-surgical error in the targeted refraction or the use of gas during the surgery. This hypothesis was used in previous studies as well.4,5
  3. We do not think that a non-significant subclinical edema is a significant bias in our study as it was not considered in other studies. Additionally, it likely could not explain more than 50–100 µm, as a larger increase in corneal thickness would result in clinically significant corneal edema. Furthermore, in our studies the biometric measurements were performed prior to surgery and then at least a few weeks after it, and at both times even sub-clinical corneal edema is not likely to have been present.
  4. Regarding the post-operative axial length (AL) we do not agree that an increased AL is necessarily expected. Vander Mijnsbrugge et al2 measured postoperative AL and also did not find a significant difference.
  5. We agree that the non-significant difference between groups could be explained by limited number of examined patients, and have noted this point as a limitation of our study. A larger number of patients and a comparison to non-vitrectomized eyes could provide more information.


The authors report no conflicts of interest in this communication.


1. Falkner-Radler CI, Benesch T, Binder S. Accuracy of preoperative biometry in vitrectomy combined with cataract surgery for patients with epiretinal membranes and macular holes. Results of a prospective controlled clinical trial. J Cataract Refract Surg. 2013;39:942–947. doi:10.1016/j.jcrs.2013.04.012

2. Vander Mijnsbrugge J, Fils JF, Jansen J, Hua MT, Stalmans P. The role of the vitreous body in effective IOL positioning. Graefes Arch Clin Exp Ophthalmol. 2018;256(8):1517–1520. doi:10.1007/s00417-018-3994-9

3. Wagenfeld L, Hermsdorf K, Stemplewitz B, Druchkiv V, Frings A. Refractive predictability in eyes with intraocular gas tamponade – results of a prospective controlled clinical trial. Clin Ophthalmol. 2017;11:993–998. doi:10.2147/OPTH.S132644

4. Shiraki N, Wakabayashi T, Sakaguchi H, Nishida K. Effect of gas tamponade on the intraocular lens position and refractive error after phacovitrectomy: a swept-source anterior segment OCT analysis. Ophthalmology. 2020;127(4):511–515. doi:10.1016/j.ophtha.2019.10.021

5. Schweitzer KD, Garcıa R. Myopic shift after combined phacoemulsification and vitrectomy with gas tamponade. Can J Ophthalmol. 2008;43:581–583. doi:10.3129/i08-135

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.